Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
about
BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slicesStriatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome.Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory.Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell culturesMPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's DiseaseTargeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro.Estrogen-growth factor interactions and their contributions to neurological disordersA dual-hit animal model for age-related parkinsonism.The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.Cell-based therapies for Parkinson's disease.Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis.TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.Pharmacogenetics of drug response in Parkinson's disease.De-repressing LncRNA-Targeted Genes to Upregulate Gene Expression: Focus on Small Molecule TherapeuticsSurvival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.Ca2+, CREB and krüppel: a novel KLF7-binding element conserved in mouse and human TRKB promoters is required for CREB-dependent transcriptionResveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism.Novel insights in pharmacogenetics of drug response in Parkinson's disease.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects.Maternal inheritance of BDNF deletion, with phenotype of obesity and developmental delay in mother and child.Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson's disease: a systematic review and meta-analysis.The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery
P2860
Q28241512-E43EA853-1590-448F-AC4A-A86E14B2E60EQ33578074-33249C60-81C4-4BBD-9F63-E28951AD945AQ33819127-B9DF0B85-FB30-4200-ABA3-3A101EA7C257Q33872721-D92AF319-DA8B-4E0E-BCB7-326F63978052Q34000281-C0A1B761-8B0E-4866-992E-12B4ABACE708Q34111160-11837D67-FE78-4999-BADE-8703702A5455Q34548310-250A3392-F4CA-46C1-A44E-975EFFD623C7Q35484424-FB61F004-7BA0-4415-AFBD-829DF80B3502Q36494212-856C7E5B-3350-41C1-B7D6-651995AC19D2Q36725915-C40724ED-10AA-4D01-939D-A755EF0FD4B1Q37242949-9D8028D6-68CB-4A4B-BFAD-E5039363AB75Q37620482-4ABA21CB-9CD2-4A59-AEDA-CEA4F1C3F999Q37728184-2FBBBD21-E8D2-41B0-9F42-90B70220098CQ37886149-F9544E3F-C852-4DB1-97B3-1BC216B06DBEQ38101109-55756431-8196-49EE-BBD3-1EA7C572D3B1Q38106649-5E73ADDD-4442-4FDA-BF8B-BF9664647D48Q38250117-7E82596E-0265-4A93-A3C6-194FA05C1FD1Q38269075-9B6AC653-A77B-40EE-A8CE-880C7C98E953Q41378145-2AAC51A9-50B1-4DA4-9719-538398A8C2C7Q41939307-95C8E22D-F3E0-49A9-8A01-B902E5336095Q42320739-E44C248F-AA7C-4BAF-8F83-94E37559007DQ43171707-7ABAB4CD-1E33-415B-935A-4E14EFE2D244Q47102033-D0DDCA5C-4A88-4B11-B04F-24795D776C51Q47389217-B61CDBDE-76B4-4772-958F-1B8B0BBFEB8EQ48215694-FF342735-7CF7-4588-BEA2-EBAE91C6A9B1Q52686249-40BED35D-5487-4DE3-B7CA-5B20BE5340B2Q55278902-AA2B7914-EACD-4B93-BE7D-FA47FDE8EA55Q57176938-DD51540E-930F-4D95-AB67-05163AD03E76
P2860
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@ast
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@en
type
label
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@ast
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@en
prefLabel
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@ast
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
@en
P2860
P356
P1476
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500360
P577
2006-03-01T00:00:00Z